From the Health Affairs Blog:
On Thursday, October 11, Health Affairs will hold a briefing to unveil its October 2012 issue, “Current Challenges In Comparative Effectiveness Research.” The volume examines how findings from comparative effectiveness research will be communicated, particularly if they pertain to prescription drugs and if the findings could be useful for promotional purposes yet fall short of the standard of “substantial evidence” required by the Food and Drug Administration (FDA) under federal law.
The cluster of articles includes a hypothetical case study of comparative effectiveness research involving a fictional migraine drug and a symposium of analyses and responses follows from various stakeholders. The issue received funding support from the National Pharmaceutical Council.
Please join us for a briefing at the Washington Marriott at Metro Center on Thursday, October 11, 8:30 a.m. – 12:30 p.m., as we unveil the issue. Register by clicking here or by going to https://events.r20.constantcontact.com/register/eventReg?llr=tcmi8ydab&oeidk=a07e6fg62xrf0a8dd14
Read the complete post here.